Aspirin offers no benefit for people with rare genetic variants: study

​Regular use of aspirin or other non-steroidal anti-inflammatory drugs (NSAID) can reduce most people's colorectal cancer risk but a few individuals with rare genetic variants do not share this benefit, a study suggested Tuesday.

Xinhua

Xinhua

10 Years ago

Health colorectal genetic who people cancer